# Xellia Pharmaceuticals ApS - Inspection Records

Source: https://www.keypedia.com/companies/xellia-pharmaceuticals-aps/c7eb4994-f4a0-4542-9239-1c18dacef0e6

> Inspection records and compliance data for Xellia Pharmaceuticals ApS in Copenhagen S, N/A. Access full analysis and detailed observations.

---

## Details

- Name: Xellia Pharmaceuticals ApS
- City: Copenhagen S
- State: N/A
- Country Name: Canada
- Address Line 1: Dalslandsgade 11
- Zip Code: 2300

## Related Documents

- [Canada Inspection - Xellia Pharmaceuticals ApS - Inspection #87283 - 2023-10-05](https://www.keypedia.com/records/canada_inspection/xellia-pharmaceuticals-aps/d6fc718a-5f49-4347-b653-3a76971d2c17) — source: Canada, date: October 5, 2023
- [Canada Inspection - Xellia Pharmaceuticals ApS - Inspection #81608 - 2021-10-28](https://www.keypedia.com/records/canada_inspection/xellia-pharmaceuticals-aps/de2a989a-5999-414a-a4da-e4564270ffe2) — source: Canada, date: October 28, 2021
- [Canada Inspection - Xellia Pharmaceuticals ApS - Inspection #76775 - 2019-10-25](https://www.keypedia.com/records/canada_inspection/xellia-pharmaceuticals-aps/6f9d5b86-f9a0-4947-9c4a-66d80ca3bb6e) — source: Canada, date: October 25, 2019
- [Canada Inspection - Xellia Pharmaceuticals ApS - Inspection #76752 - 2019-10-10](https://www.keypedia.com/records/canada_inspection/xellia-pharmaceuticals-aps/d556c7fe-42b3-4c16-a39f-ff56a4b4ecfa) — source: Canada, date: October 10, 2019
- [Canada Inspection - Xellia Pharmaceuticals ApS - Inspection #70247 - 2017-08-17](https://www.keypedia.com/records/canada_inspection/xellia-pharmaceuticals-aps/40e5947d-bd2a-4a14-be2c-4c1f9d5f2cc6) — source: Canada, date: August 17, 2017
- [Canada Inspection - Xellia Pharmaceuticals ApS - Inspection #70210 - 2017-08-10](https://www.keypedia.com/records/canada_inspection/xellia-pharmaceuticals-aps/91955ff9-0d29-49ab-9c89-70ca9e49dc1e) — source: Canada, date: August 10, 2017
- [Canada Inspection - Xellia Pharmaceuticals ApS - Inspection #17861 - 2015-08-27](https://www.keypedia.com/records/canada_inspection/xellia-pharmaceuticals-aps/5d52fcdb-29c5-4eec-ac69-1af956c13b34) — source: Canada, date: August 27, 2015
- [Canada Inspection - Xellia Pharmaceuticals ApS - Inspection #17541 - 2015-08-13](https://www.keypedia.com/records/canada_inspection/xellia-pharmaceuticals-aps/ce5a451e-5ed9-40e8-8206-ed8da910c6d7) — source: Canada, date: August 13, 2015
- [Canada Inspection - Xellia Pharmaceuticals ApS - Inspection #1061 - 2013-04-11](https://www.keypedia.com/records/canada_inspection/xellia-pharmaceuticals-aps/84b857ff-44ff-4609-83e1-b87b9b7a948c) — source: Canada, date: April 11, 2013
- [Canada Inspection - Xellia Pharmaceuticals ApS - Inspection #13443 - 2012-09-19](https://www.keypedia.com/records/canada_inspection/xellia-pharmaceuticals-aps/5ba5d7ef-b47c-4298-8bba-a76d136df311) — source: Canada, date: September 19, 2012

## Related Companies

- [AstraZeneca AB](https://www.keypedia.com/companies/astrazeneca-ab/a70f18df-57e0-4a18-b898-e51d76a67f37)
- [Baxter Healthcare Corporation](https://www.keypedia.com/companies/baxter-healthcare-corporation/423140fe-c265-4bca-a8da-34ee943c5378)
- [Novo Nordisk A/S](https://www.keypedia.com/companies/novo-nordisk-as/2522e48f-143e-4ae8-9b09-9d2f60c84321)
- [Olon S.p.A.](https://www.keypedia.com/companies/olon-spa/9b536927-3235-4b50-88e1-9252a76e9d19)
- [ACS Dobfar S.P.A.](https://www.keypedia.com/companies/acs-dobfar-spa/47f2473f-1510-4e5e-b84b-0f0f41c7a820)
- [Lek Pharmaceuticals d.d.](https://www.keypedia.com/companies/lek-pharmaceuticals-dd/6270f98c-f7d4-4ab2-b047-247854fc55f4)
- [Sanofi Chimie](https://www.keypedia.com/companies/sanofi-chimie/a6a658f3-1386-4dcf-baf7-2b568996f298)
- [Incepta Pharmaceuticals Limited](https://www.keypedia.com/companies/incepta-pharmaceuticals-limited/531407dc-a2c8-42a5-9394-751d1e4cf5de)
- [Celltrion Pharm Inc](https://www.keypedia.com/companies/celltrion-pharm-inc/56dd83f1-7490-44fd-a3ae-612f362f9c2a)
- [Fresenius Kabi USA LLC](https://www.keypedia.com/companies/fresenius-kabi-usa-llc/7548720b-e1a5-47dc-80e7-14b8fdd3e2f3)